Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07317115 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Side-to-Side Duodeno-ileostomy Versus Semaglutide in Adults With Obesity and Type 2 Diabetes

Study acronym: MAGvMED
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Start date changed from estimate of Mar 2026 to Mar 18, 2026v3
  2. Start date: Jan 2026 to Mar 2026v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
GT Metabolic Solutions, Inc.
11 trials monitored
See 1 trial at risk
Diabetes
5,087 trials monitored
See 222 trials at risk
Obesity
3,874 trials monitored
See 152 trials at risk
Type 2 Diabetes
2,231 trials monitored
See 111 trials at risk
Compare use of the Magnet System in side-to-side duodeno-ileostomy (Surgery) with semaglutide (Medication).
Trial Details
NCT Number NCT07317115
Lead Sponsor GT Metabolic Solutions, Inc.
Conditions
(from sponsor)		 Obesity (Disorder), Obesity & Overweight, Type 2 Diabetes (T2DM)
Related terms Diabetes Mellitus, Type 2, Obesity, Overweight
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov